- Home
- IMOS vs CATX Comparison
IMOS vs CATX Comparison
Compare IMOS & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMOS
- CATX
- Stock Information
- Founded
- IMOS 1997
- CATX 1983
- Country
- IMOS Taiwan
- CATX United States
- Employees
- IMOS N/A
- CATX N/A
- Industry
- IMOS Semiconductors
- CATX Medical/Dental Instruments
- Sector
- IMOS Technology
- CATX Health Care
- Exchange
- IMOS Nasdaq
- CATX Nasdaq
- Market Cap
- IMOS 813.1M
- CATX 782.7M
- IPO Year
- IMOS N/A
- CATX N/A
- Fundamental
- Price
- IMOS $19.19
- CATX $3.28
- Analyst Decision
- IMOS
- CATX Strong Buy
- Analyst Count
- IMOS 0
- CATX 9
- Target Price
- IMOS N/A
- CATX $17.25
- AVG Volume (30 Days)
- IMOS 27.3K
- CATX 2.7M
- Earning Date
- IMOS 11-05-2024
- CATX 11-12-2024
- Dividend Yield
- IMOS 6.10%
- CATX N/A
- EPS Growth
- IMOS 7.03
- CATX N/A
- EPS
- IMOS 0.07
- CATX N/A
- Revenue
- IMOS $724,842,895.00
- CATX $1,557,000.00
- Revenue This Year
- IMOS $15.65
- CATX N/A
- Revenue Next Year
- IMOS $13.49
- CATX N/A
- P/E Ratio
- IMOS $12.84
- CATX N/A
- Revenue Growth
- IMOS 13.31
- CATX N/A
- 52 Week Low
- IMOS $18.20
- CATX $2.50
- 52 Week High
- IMOS $32.19
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- IMOS 42.28
- CATX 20.61
- Support Level
- IMOS $18.20
- CATX $3.07
- Resistance Level
- IMOS $19.40
- CATX $3.60
- Average True Range (ATR)
- IMOS 0.24
- CATX 0.30
- MACD
- IMOS 0.01
- CATX 0.21
- Stochastic Oscillator
- IMOS 55.88
- CATX 1.03
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. The Company derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.